Skip to main content
Top
Published in: Cardiovascular Toxicology 2/2018

01-04-2018

Xanthine Oxidase Activation Modulates the Endothelial (Vascular) Dysfunction Related to HgCl2 Exposure Plus Myocardial Infarction in Rats

Authors: Thaís de O. Faria, Maylla Ronacher Simões, Dalton Valentim Vassallo, Ludimila Forechi, Camila Cruz Pereira Almenara, Bruna Antoniassi Marchezini, Ivanita Stefanon, Paula Frizera Vassallo

Published in: Cardiovascular Toxicology | Issue 2/2018

Login to get access

Abstract

Heavy metal exposure is associated with cardiovascular diseases such as myocardial infarction (MI). Vascular dysfunction is related to both the causes and the consequences of MI. We investigated whether chronic exposure to low doses of mercury chloride (HgCl2) worsens MI-induced endothelial dysfunction 7 days after MI. Male Wistar rats were divided into four groups: Control (vehicle), HgCl2 (4 weeks of exposure), surgically induced MI and combined HgCl2-MI. Morphological and hemodynamic measurements were used to characterize the MI model 7 days after the insult. Vascular reactivity was evaluated in aortic rings. Chronic HgCl2 exposure did not cause more heart injury than MI alone in terms of the morphological or hemodynamic parameters. Vascular reactivity increased in all groups, but the combination of HgCl2-MI increased the vasorelaxation induced by ACh compared with the HgCl2 and MI groups. Results showed reduced endothelial nitric oxide synthase (eNOS) protein expression in the MI group; increased iNOS activity in the HgCl2-MI group, although without enough magnitude to reverse the reduction in NO bioavailability; and increased phenylephrine response in the HgCl2-MI group due to an increase in ROS production, notably via xanthine oxidase (XO). Results suggest that the combination of 1 month pre-exposure of HgCl2 before MI changed the endothelial generation of oxidative stress induced by mercury exposure from NADPH oxidase pathway to XO (xanthine oxidase)-dependent ROS production.
Literature
1.
go back to reference Clarkson, T. W., Magos, L., & Myers, G. J. (2003). The toxicology of mercury—current exposures and clinical manifestations. The New England Journal of Medicine, 349, 1731–1737.CrossRefPubMed Clarkson, T. W., Magos, L., & Myers, G. J. (2003). The toxicology of mercury—current exposures and clinical manifestations. The New England Journal of Medicine, 349, 1731–1737.CrossRefPubMed
2.
go back to reference Langworth, S., Sällsten, G., Barregard, L., Cynkier, I., Lind, M. L., & Söderman, E. (1997). Exposure to mercury vapour and impact on health in the dental profession in Sweden. Journal of Dental Research, 76, 1397–1404.CrossRefPubMed Langworth, S., Sällsten, G., Barregard, L., Cynkier, I., Lind, M. L., & Söderman, E. (1997). Exposure to mercury vapour and impact on health in the dental profession in Sweden. Journal of Dental Research, 76, 1397–1404.CrossRefPubMed
3.
go back to reference McKelvey, W., Gwynn, R. C., Jeffery, N., Kass, D., Thorpe, L. E., Garg, R. K., et al. (2007). A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environmental Health Perspectives, 115, 1435–1441.PubMedPubMedCentral McKelvey, W., Gwynn, R. C., Jeffery, N., Kass, D., Thorpe, L. E., Garg, R. K., et al. (2007). A biomonitoring study of lead, cadmium, and mercury in the blood of New York city adults. Environmental Health Perspectives, 115, 1435–1441.PubMedPubMedCentral
4.
go back to reference Salonen, J. T., Seppänen, K., Nyyssönen, K., Korpela, H., Kauhanen, J., Kantola, M., et al. (1995). Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation, 91, 645–655.CrossRefPubMed Salonen, J. T., Seppänen, K., Nyyssönen, K., Korpela, H., Kauhanen, J., Kantola, M., et al. (1995). Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation, 91, 645–655.CrossRefPubMed
5.
go back to reference Virtanen, J. K., Voutilainen, S., Rissanen, T. H., Mursu, J., Tuomainen, T. P., Korhonen, M. J., et al. (2005). Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 228–233.PubMed Virtanen, J. K., Voutilainen, S., Rissanen, T. H., Mursu, J., Tuomainen, T. P., Korhonen, M. J., et al. (2005). Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 228–233.PubMed
6.
go back to reference Choi, A. L., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., Salonen, J. T., Tuomainen, T. P., et al. (2009). Methylmercury exposure and adverse cardiovascular effects in faroese whaling men. Environmental Health Perspectives, 117(3), 367–372.CrossRefPubMed Choi, A. L., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., Salonen, J. T., Tuomainen, T. P., et al. (2009). Methylmercury exposure and adverse cardiovascular effects in faroese whaling men. Environmental Health Perspectives, 117(3), 367–372.CrossRefPubMed
7.
go back to reference Vassallo, D. V., Simões, M. R., Furieri, L. B., Fioresi, M., Fiorim, J., Almeida, E. A., et al. (2011). Toxic effects of mercury, lead and gadolinium on vascular reactivity. Brazilian Journal of Medical and Biological Research, 44, 939–946.CrossRefPubMed Vassallo, D. V., Simões, M. R., Furieri, L. B., Fioresi, M., Fiorim, J., Almeida, E. A., et al. (2011). Toxic effects of mercury, lead and gadolinium on vascular reactivity. Brazilian Journal of Medical and Biological Research, 44, 939–946.CrossRefPubMed
8.
go back to reference Lemos, N. B., Angeli, J. K., Faria, T. de O., Ribeiro Junior, R. F., Vassallo, D. V., Padilha, A. S., et al. (2012). Low mercury concentration produces vasoconstriction, decreases nitric oxide bioavailability and increases oxidative stress in rat conductance artery. PLoS ONE, 7(11), e49005.CrossRefPubMedPubMedCentral Lemos, N. B., Angeli, J. K., Faria, T. de O., Ribeiro Junior, R. F., Vassallo, D. V., Padilha, A. S., et al. (2012). Low mercury concentration produces vasoconstriction, decreases nitric oxide bioavailability and increases oxidative stress in rat conductance artery. PLoS ONE, 7(11), e49005.CrossRefPubMedPubMedCentral
9.
go back to reference Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., et al. (2013). The vascular endothelium and human diseases. International Journal of Biological Sciences, 9, 1057–1069.CrossRefPubMedPubMedCentral Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., et al. (2013). The vascular endothelium and human diseases. International Journal of Biological Sciences, 9, 1057–1069.CrossRefPubMedPubMedCentral
10.
go back to reference Guallar, E., Sanz-Gallardo, M. I., van’t Veer, P., Bode, O., Aro, A., Gómez-Aracena, J., et al. (2002). Mercury, fish oils, and the risk of myocardial infarction. The New England Journal of Medicine, 347, 1747–1754.CrossRefPubMed Guallar, E., Sanz-Gallardo, M. I., van’t Veer, P., Bode, O., Aro, A., Gómez-Aracena, J., et al. (2002). Mercury, fish oils, and the risk of myocardial infarction. The New England Journal of Medicine, 347, 1747–1754.CrossRefPubMed
11.
go back to reference Houston, M. C. (2007). The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Alternative Therapies in Health and Medicine, 13, S128–S133.PubMed Houston, M. C. (2007). The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Alternative Therapies in Health and Medicine, 13, S128–S133.PubMed
12.
go back to reference Houston, M. C. (2011). Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. Journal of Clinical Hypertension (Greenwich), 13, 621–627.CrossRef Houston, M. C. (2011). Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. Journal of Clinical Hypertension (Greenwich), 13, 621–627.CrossRef
13.
go back to reference Park, S. K., Lee, S., Basu, N., & Franzblau, A. (2013). Associations of blood and urinary mercury with hypertension in U.S. adults: The NHANES 2003–2006. Environmental Research, 123, 25–32.CrossRefPubMedPubMedCentral Park, S. K., Lee, S., Basu, N., & Franzblau, A. (2013). Associations of blood and urinary mercury with hypertension in U.S. adults: The NHANES 2003–2006. Environmental Research, 123, 25–32.CrossRefPubMedPubMedCentral
14.
go back to reference Furieri, L. B., Galán, M., Avendaño, M. S., García-Redondo, A. B., Aguado, A., Martínez, S., et al. (2011). Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. British Journal of Pharmacology, 162, 1819–1831.CrossRefPubMedPubMedCentral Furieri, L. B., Galán, M., Avendaño, M. S., García-Redondo, A. B., Aguado, A., Martínez, S., et al. (2011). Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species. British Journal of Pharmacology, 162, 1819–1831.CrossRefPubMedPubMedCentral
15.
go back to reference Peçanha, F. M., Wiggers, G. A., Briones, A. M., Perez-Giron, J. V., Miguel, M., Garcia-Redondo, A. B., et al. (2010). The role of cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to phenylephrine is increased by exposure to mercury concentration. Journal of Physiology and Pharmacology, l61(1), 29–36. Peçanha, F. M., Wiggers, G. A., Briones, A. M., Perez-Giron, J. V., Miguel, M., Garcia-Redondo, A. B., et al. (2010). The role of cyclooxygenase (COX)-2 derived prostanoids on vasoconstrictor responses to phenylephrine is increased by exposure to mercury concentration. Journal of Physiology and Pharmacology, l61(1), 29–36.
16.
go back to reference Kishimoto, T., Oguri, T., & Tada, M. (1995). Effect of methylmercury (CH3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology, 103, 1–7.CrossRefPubMed Kishimoto, T., Oguri, T., & Tada, M. (1995). Effect of methylmercury (CH3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology, 103, 1–7.CrossRefPubMed
17.
go back to reference Salonen, J. T., Seppanen, K., Lakka, T. A., Salonen, R., & Kaplan, G. A. (2000). Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis, 148, 265–273.CrossRefPubMed Salonen, J. T., Seppanen, K., Lakka, T. A., Salonen, R., & Kaplan, G. A. (2000). Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis, 148, 265–273.CrossRefPubMed
18.
go back to reference Harja, E., Bu, D. X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., et al. (2008). Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE −/− mice. The Journal of Clinical Investigation, 118, 183–194.CrossRefPubMed Harja, E., Bu, D. X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., et al. (2008). Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE −/− mice. The Journal of Clinical Investigation, 118, 183–194.CrossRefPubMed
19.
go back to reference Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2013). Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation, 127, e6–e245.CrossRefPubMed Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., et al. (2013). Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation, 127, e6–e245.CrossRefPubMed
20.
go back to reference Faria, T. de O., Baldo, M. P., Simões, M. R., Pereira, R. B., Mill, J. G., Vassallo, D. V., et al. (2011). Body weight loss after myocardial infarction in rats as a marker of early heart failure development. Archives of Medical Research, 42, 274–280.CrossRef Faria, T. de O., Baldo, M. P., Simões, M. R., Pereira, R. B., Mill, J. G., Vassallo, D. V., et al. (2011). Body weight loss after myocardial infarction in rats as a marker of early heart failure development. Archives of Medical Research, 42, 274–280.CrossRef
21.
go back to reference Mill, J. G., Stefanon, I., dos Santos, L., & Baldo, M. P. (2011). Remodeling in the ischemic heart: the stepwise progression for heart failure. Brazilian Journal of Medical and Biological Research, 44, 890–898.CrossRefPubMed Mill, J. G., Stefanon, I., dos Santos, L., & Baldo, M. P. (2011). Remodeling in the ischemic heart: the stepwise progression for heart failure. Brazilian Journal of Medical and Biological Research, 44, 890–898.CrossRefPubMed
22.
go back to reference Stefanon, I., Valero-Muñoz, M., Fernandes, A. A., Ribeiro, R. F., Jr., Rodríguez, C., Miana, M., et al. (2013). Left and right ventricle late remodeling following myocardial infarction in rats. PLoS ONE, 8, e64986.CrossRefPubMedPubMedCentral Stefanon, I., Valero-Muñoz, M., Fernandes, A. A., Ribeiro, R. F., Jr., Rodríguez, C., Miana, M., et al. (2013). Left and right ventricle late remodeling following myocardial infarction in rats. PLoS ONE, 8, e64986.CrossRefPubMedPubMedCentral
23.
go back to reference Bauersachs, J., & Widder, J. D. (2008). Endothelial dysfunction in heart failure. Pharmacological Reports, 60, 119–126.PubMed Bauersachs, J., & Widder, J. D. (2008). Endothelial dysfunction in heart failure. Pharmacological Reports, 60, 119–126.PubMed
24.
go back to reference Förstermann, U. (2008). Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nature Clinical Practice Cardiovascular Medicine, 5, 338–349.CrossRefPubMed Förstermann, U. (2008). Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nature Clinical Practice Cardiovascular Medicine, 5, 338–349.CrossRefPubMed
25.
go back to reference Weseler, A. R., & Bast, A. (2010). Oxidative stress and vascular function: implications for pharmacologic treatment. Current Hypertension Reports, 12, 154–161.CrossRefPubMedPubMedCentral Weseler, A. R., & Bast, A. (2010). Oxidative stress and vascular function: implications for pharmacologic treatment. Current Hypertension Reports, 12, 154–161.CrossRefPubMedPubMedCentral
26.
go back to reference Abbate, A., Santini, D., Biondi-Zoccai, G. G. L., Scarpa, S., Vasaturo, F., Liuzzo, G., et al. (2004). Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart, 90(4), 440–443.CrossRefPubMedPubMedCentral Abbate, A., Santini, D., Biondi-Zoccai, G. G. L., Scarpa, S., Vasaturo, F., Liuzzo, G., et al. (2004). Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart, 90(4), 440–443.CrossRefPubMedPubMedCentral
27.
go back to reference Looi, Y. H., Grieve, D. J., Siva, A., Walker, S. J., Anilkumar, N., Cave, A. C., et al. (2008). Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension, 51(2), 319–325.CrossRefPubMed Looi, Y. H., Grieve, D. J., Siva, A., Walker, S. J., Anilkumar, N., Cave, A. C., et al. (2008). Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension, 51(2), 319–325.CrossRefPubMed
28.
go back to reference Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., et al. (2002). Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation, 106, 3073–3078.CrossRefPubMed Landmesser, U., Spiekermann, S., Dikalov, S., Tatge, H., Wilke, R., et al. (2002). Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation, 106, 3073–3078.CrossRefPubMed
29.
go back to reference Engberding, N., Spiekermann, S., Schaefer, A., Heineke, A., Wiencke, A., Müller, M., et al. (2004). Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug. Circulation, 110, 2175–2179.CrossRefPubMed Engberding, N., Spiekermann, S., Schaefer, A., Heineke, A., Wiencke, A., Müller, M., et al. (2004). Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug. Circulation, 110, 2175–2179.CrossRefPubMed
30.
go back to reference Zweier, J. L., & Talukder, M. A. (2006). The role of oxidants and free radicals in 32 reperfusion injury. Cardiovascular Research, 70(2), 181–190.CrossRefPubMed Zweier, J. L., & Talukder, M. A. (2006). The role of oxidants and free radicals in 32 reperfusion injury. Cardiovascular Research, 70(2), 181–190.CrossRefPubMed
31.
go back to reference Sagor, M. A., Tabassum, N., Potol, M. A., & Alam, M. A. (2015). Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats. Oxidative Medicine and Cellular Longevity, 2015, 478039.CrossRefPubMedPubMedCentral Sagor, M. A., Tabassum, N., Potol, M. A., & Alam, M. A. (2015). Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats. Oxidative Medicine and Cellular Longevity, 2015, 478039.CrossRefPubMedPubMedCentral
32.
go back to reference da Cunha, V., Stefanon, I., & Mill, J. G. (2004). The role of nitric oxide in mediating cardiovascular alterations accompanying heart failure in rats. Canadian Journal of Physiology and Pharmacology, 82, 372–379.CrossRefPubMed da Cunha, V., Stefanon, I., & Mill, J. G. (2004). The role of nitric oxide in mediating cardiovascular alterations accompanying heart failure in rats. Canadian Journal of Physiology and Pharmacology, 82, 372–379.CrossRefPubMed
33.
go back to reference Sartório, C. L., Pinto, V. D., Cutini, G. J., Vassallo, D. V., & Stefanon, I. (2005). Effects of inducible nitric oxide syinthase inhibition on the rat tail vascular bed reactivity three days after myocardial infarction. Journal of Cardiovascular Pharmacology, 45, 321–326.CrossRefPubMed Sartório, C. L., Pinto, V. D., Cutini, G. J., Vassallo, D. V., & Stefanon, I. (2005). Effects of inducible nitric oxide syinthase inhibition on the rat tail vascular bed reactivity three days after myocardial infarction. Journal of Cardiovascular Pharmacology, 45, 321–326.CrossRefPubMed
34.
go back to reference Faria, T. de O., Costa, G. P., Almenara, C. C., Angeli, J. K., Vassallo, D. V., Stefanon, I., et al. (2014). Chronic exposure to low doses of HgCl2 avoids calcium handling impairment in the right ventricle after myocardial infarction in rats. PLoS ONE, 9(4), e95639.CrossRefPubMedCentral Faria, T. de O., Costa, G. P., Almenara, C. C., Angeli, J. K., Vassallo, D. V., Stefanon, I., et al. (2014). Chronic exposure to low doses of HgCl2 avoids calcium handling impairment in the right ventricle after myocardial infarction in rats. PLoS ONE, 9(4), e95639.CrossRefPubMedCentral
35.
go back to reference Wiggers, G. A., Peçanha, F. M., Briones, A. M., Pérez-Girón, J. V., Miguel, M., Vassallo, D. V., et al. (2008). Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. American Journal of Physiology Heart and Circulatory Physiology, 295, H1033–H1043.CrossRefPubMed Wiggers, G. A., Peçanha, F. M., Briones, A. M., Pérez-Girón, J. V., Miguel, M., Vassallo, D. V., et al. (2008). Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. American Journal of Physiology Heart and Circulatory Physiology, 295, H1033–H1043.CrossRefPubMed
36.
go back to reference Gupta, M., Bansal, J. K., & Khanna, C. M. (1996). Blood mercury in workers exposed to the preparation of mercury cadmium telluride layers on cadmium telluride base. Industrial Health, 34, 421–425.CrossRefPubMed Gupta, M., Bansal, J. K., & Khanna, C. M. (1996). Blood mercury in workers exposed to the preparation of mercury cadmium telluride layers on cadmium telluride base. Industrial Health, 34, 421–425.CrossRefPubMed
37.
go back to reference Chen, C., Qu, L., Li, B., Xing, L., Jia, G., Wang, T., et al. (2005). Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clinical Chemistry, 51, 759–767.CrossRefPubMed Chen, C., Qu, L., Li, B., Xing, L., Jia, G., Wang, T., et al. (2005). Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clinical Chemistry, 51, 759–767.CrossRefPubMed
38.
go back to reference George, J., & Struthers, A. D. (2009). Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vascular Health and Risk Management, 5, 265–272.CrossRefPubMedPubMedCentral George, J., & Struthers, A. D. (2009). Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vascular Health and Risk Management, 5, 265–272.CrossRefPubMedPubMedCentral
39.
go back to reference O’Rourke, M. F., & Pauca, A. L. (2004). Augmentation of the aortic and central arterial pressure waveform. Blood Pressure Monitoring, 9, 179–185.CrossRefPubMed O’Rourke, M. F., & Pauca, A. L. (2004). Augmentation of the aortic and central arterial pressure waveform. Blood Pressure Monitoring, 9, 179–185.CrossRefPubMed
40.
go back to reference Rizzetti, D. A., Torres, J. G., Escobar, A. G., Peçanha, F. M., Santos, F. W., Puntel, R. L., et al. (2013). Apocynin prevents vascular effects caused by chronic exposure to low concentrations of mercury. PLoS ONE, 8, e55806.CrossRefPubMedPubMedCentral Rizzetti, D. A., Torres, J. G., Escobar, A. G., Peçanha, F. M., Santos, F. W., Puntel, R. L., et al. (2013). Apocynin prevents vascular effects caused by chronic exposure to low concentrations of mercury. PLoS ONE, 8, e55806.CrossRefPubMedPubMedCentral
41.
go back to reference Furieri, L. B., Fioresi, M., Junior, R. F., Bartolomé, M. V., Fernandes, A. A., Cachofeiro, V., et al. (2011). Exposure to low mercury concentration in vivo impairs myocardial contractile function. Toxicology and Applied Pharmacology, 255(2), 193–199. doi:10.1016/j.taap.2011.06.015.CrossRefPubMed Furieri, L. B., Fioresi, M., Junior, R. F., Bartolomé, M. V., Fernandes, A. A., Cachofeiro, V., et al. (2011). Exposure to low mercury concentration in vivo impairs myocardial contractile function. Toxicology and Applied Pharmacology, 255(2), 193–199. doi:10.​1016/​j.​taap.​2011.​06.​015.CrossRefPubMed
42.
43.
go back to reference Hare, J. M., & Stamler, J. S. (2005). NO/Redox disequilibrium in the failing heart and cardiovascular system. The Journal of Clinical Investigation, 115, 509–517.CrossRefPubMedPubMedCentral Hare, J. M., & Stamler, J. S. (2005). NO/Redox disequilibrium in the failing heart and cardiovascular system. The Journal of Clinical Investigation, 115, 509–517.CrossRefPubMedPubMedCentral
44.
go back to reference Ahn, B., Beharry, A. W., Frye, G. S., Judge, A. R., & Ferreira, L. F. (2015). NAD(P)H oxidase subunit p47phox knockout prevents diaphragm contractile dysfunction in heart failures. American Journal of Physiology. Lung Cellular and Molecular Physiology, 309, L497–L505.CrossRefPubMedPubMedCentral Ahn, B., Beharry, A. W., Frye, G. S., Judge, A. R., & Ferreira, L. F. (2015). NAD(P)H oxidase subunit p47phox knockout prevents diaphragm contractile dysfunction in heart failures. American Journal of Physiology. Lung Cellular and Molecular Physiology, 309, L497–L505.CrossRefPubMedPubMedCentral
45.
go back to reference Xiao, J., She, Q., Wang, Y., Luo, K., Yin, Y., Hu, R., et al. (2009). Effect of allopurinol on cardiomyocyte apoptopsis in rats after myocardial infarction. European Journal of Heart Failure, 11, 20–27.CrossRefPubMed Xiao, J., She, Q., Wang, Y., Luo, K., Yin, Y., Hu, R., et al. (2009). Effect of allopurinol on cardiomyocyte apoptopsis in rats after myocardial infarction. European Journal of Heart Failure, 11, 20–27.CrossRefPubMed
46.
go back to reference Cai, H., & Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular disease: The role of oxidative stress. Circulation Research, 87, 840–844.CrossRefPubMed Cai, H., & Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular disease: The role of oxidative stress. Circulation Research, 87, 840–844.CrossRefPubMed
47.
go back to reference Förstermann, U. (2010). Nitric oxide and oxidative stress in vascular disease. Pflügers Archv, 459, 923–939.CrossRef Förstermann, U. (2010). Nitric oxide and oxidative stress in vascular disease. Pflügers Archv, 459, 923–939.CrossRef
Metadata
Title
Xanthine Oxidase Activation Modulates the Endothelial (Vascular) Dysfunction Related to HgCl2 Exposure Plus Myocardial Infarction in Rats
Authors
Thaís de O. Faria
Maylla Ronacher Simões
Dalton Valentim Vassallo
Ludimila Forechi
Camila Cruz Pereira Almenara
Bruna Antoniassi Marchezini
Ivanita Stefanon
Paula Frizera Vassallo
Publication date
01-04-2018
Publisher
Springer US
Published in
Cardiovascular Toxicology / Issue 2/2018
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-017-9427-x

Other articles of this Issue 2/2018

Cardiovascular Toxicology 2/2018 Go to the issue